Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.
Landon-Cardinal O, Friedman D, Guiguet M, Laforêt P, Heming N, Salort-Campana E, Jouen F, Allenbach Y, Boyer O, Chatenoud L, Eymard B, Sharshar T, Benveniste O. Landon-Cardinal O, et al. Among authors: guiguet m. J Neuromuscul Dis. 2018;5(2):241-249. doi: 10.3233/JND-180300. J Neuromuscul Dis. 2018. PMID: 29865089 Clinical Trial.
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.
Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L, Jouen F, Jacquot S, Mariampillai K, Musset L, Grenier P, Devilliers H, Hij A, Boyer O, Herson S, Benveniste O. Allenbach Y, et al. Among authors: guiguet m. PLoS One. 2015 Nov 5;10(11):e0133702. doi: 10.1371/journal.pone.0133702. eCollection 2015. PLoS One. 2015. PMID: 26539981 Free PMC article. Clinical Trial.
Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O. Benveniste O, et al. Among authors: guiguet m. Arthritis Rheum. 2011 Jul;63(7):1961-71. doi: 10.1002/art.30344. Arthritis Rheum. 2011. PMID: 21400483 Free article.
Long-term observational study of sporadic inclusion body myositis.
Benveniste O, Guiguet M, Freebody J, Dubourg O, Squier W, Maisonobe T, Stojkovic T, Leite MI, Allenbach Y, Herson S, Brady S, Eymard B, Hilton-Jones D. Benveniste O, et al. Among authors: guiguet m. Brain. 2011 Nov;134(Pt 11):3176-84. doi: 10.1093/brain/awr213. Epub 2011 Oct 12. Brain. 2011. PMID: 21994327
Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O. Stanciu R, et al. Among authors: guiguet m. J Rheumatol. 2012 Sep;39(9):1835-9. doi: 10.3899/jrheum.111604. Epub 2012 Aug 1. J Rheumatol. 2012. PMID: 22859355
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O. Mariampillai K, et al. Among authors: guiguet m. JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598. JAMA Neurol. 2018. PMID: 30208379 Free PMC article.
Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O. Hervier B, et al. Among authors: guiguet m. Autoimmun Rev. 2012 Dec;12(2):210-7. doi: 10.1016/j.autrev.2012.06.006. Epub 2012 Jul 5. Autoimmun Rev. 2012. PMID: 22771754
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.
Caby F, Valin N, Marcelin AG, Schneider L, Andrade R, Guiguet M, Tubiana R, Canestri A, Valantin MA, Peytavin G, Pacanowski J, Morand-Joubert L, Calvez V, Girard PM, Katlama C. Caby F, et al. Among authors: guiguet m. Scand J Infect Dis. 2010 Jul;42(6-7):527-32. doi: 10.3109/00365541003621502. Scand J Infect Dis. 2010. PMID: 20222846
208 results